537253 SUNLOC

Sunil Healthcare Share Price

 

 

Start SIP in SUNLOC

Start SIP

Performance

  • Low
  • ₹70
  • High
  • ₹70
  • 52 Week Low
  • ₹61
  • 52 Week High
  • ₹89
  • Open Price₹70
  • Previous Close₹72
  • Volume3

Investment Returns

  • Over 1 Month -1.92%
  • Over 3 Month -12.61%
  • Over 6 Month -11.4%
  • Over 1 Year -13.89%

Smart Investing Starts Here Start SIP with Sunil Healthcare for Steady Growth!

Invest Now

Sunil Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 41.5
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 72
  • P/B Ratio
  • 1.1
  • Average True Range
  • 3.43
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.03
  • RSI
  • 49.55
  • MFI
  • 57.76

Sunil Healthcare Financials

Sunil Healthcare Technicals

EMA & SMA

Current Price
₹70.00
-2 (-2.78%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹69.77
  • 50 Day
  • ₹71.76
  • 100 Day
  • ₹73.96
  • 200 Day
  • ₹75.56

Resistance and Support

70 Pivot Speed
  • R3 70.00
  • R2 70.00
  • R1 70.00
  • S1 70.00
  • S2 70.00
  • S3 70.00

Sunil Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-04 Quarterly Results
2025-07-30 Quarterly Results
2025-05-29 Audited Results
2025-02-13 Quarterly Results
2024-11-13 Quarterly Results

Sunil Healthcare F&O

Sunil Healthcare Shareholding Pattern

73.53%
0.1%
17.85%
8.52%

Sunil Healthcare FAQs

Sunil Healthcare share price is ₹70 As on 27 December, 2025 | 07:37

The Market Cap of Sunil Healthcare is ₹71.8 Cr As on 27 December, 2025 | 07:37

The P/E ratio of Sunil Healthcare is 41.5 As on 27 December, 2025 | 07:37

The PB ratio of Sunil Healthcare is 1.1 As on 27 December, 2025 | 07:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23